Early palliative care played a crucial role in minimizing aggressive treatment and health care costs for subjects receiving PMV. Addressing access differences across sociodemographic groups and institutional tiers is essential for promoting equitable and value-aligned end-of-life care.
Chu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: